Case Study:
Introduction
This case study examines the management of Androgen Insensitivity Syndrome (AIS) in a 20-year-old individual with a genetic mutation leading to insensitivity to dihydrotestosterone (DHT), emphasizing the hormonal and psychological aspects of care.
Patient Background
- Profile: 20-year-old individual with female external genitalia and a genetic mutation causing AIS.
- Medical History: Diagnosed with AIS during childhood, leading to a raised female.
Initial Assessment
- Clinical Presentation: The patient presented with concerns about gender identity and dissatisfaction with physical appearance.
- Diagnostic Evaluation: Genetic testing confirmed the presence of a mutation in the androgen receptor gene leading to DHT insensitivity.
Treatment Plan
- Psychological Counseling: Initiated psychological counseling to explore gender identity and provide emotional support.
- Hormone Replacement Therapy (HRT): Offered HRT to induce secondary sexual characteristics, such as breast development, to align with the patient’s gender identity.
- Ongoing Support: Ensured ongoing medical monitoring and psychological support to address emotional well-being.
Monitoring and Adjustments
- Regular Counseling: Scheduled regular counseling sessions to address evolving concerns related to gender identity.
- HRT Adjustments: Modified HRT regimen based on the patient’s preferences and goals.
Outcomes
- Short-Term (1 Year): The patient reported an improvement in psychological well-being and satisfaction with physical changes induced by HRT.
- Long-Term (3 Years): Continued positive progress in terms of gender identity, emotional well-being, and satisfaction with treatment.
Patient Feedback
- Treatment Adherence: The patient consistently adhered to the treatment plan and expressed gratitude for the supportive care received.
- Psychological Impact: Reported increased self-confidence and a stronger sense of gender identity.
Discussion
- Comprehensive Care: The management of AIS with DHT insensitivity requires a holistic approach, addressing both the hormonal and psychological aspects of the condition.
- Patient-Centered Care: The treatment plan was tailored to the patient’s gender identity and preferences, emphasizing their well-being and satisfaction.
- Ongoing Support: Regular counseling and medical monitoring are essential for addressing the evolving needs of individuals with AIS.
Conclusion
Managing AIS with DHT insensitivity involves providing personalized care that recognizes the individual’s gender identity and psychological well-being. This case study highlights the importance of a patient-centered approach and ongoing support in the care of individuals with AIS, ensuring their overall well-being and satisfaction with their chosen path.
Gender-Affirming Hormone Therapy with DHT in Transmasculine Individuals